Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function

Cytotherapy

Volumn 10, Issue 4, 2008, Pages 397-405

  Lin, S J ^a   Kuo, M L ^b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Cyclosporin; Interleukin 15; Natural killer cells; Umbilical cord blood

Indexed keywords

CD3 ANTIBODY; CD3 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; CYCLOSPORIN A; INTERLEUKIN 15; LIPOCORTIN 5; PERFORIN; TACROLIMUS;

APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET CELL; UMBILICAL CORD BLOOD;

EID: 47249128109     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240802129885     Document Type: Article

References (32)

1. Wu, J. and Lanier, LL. (2003) Natural killer cells and cancer. Adv Cancer Res, 90, pp. 127-156.
2. Farag, SS and Caligiuri, MA. (2006) Human natural killer cell development and biology. Blood Rev, 20, pp. 123-137.
3. Brunstein, CG, Sebutal, DC and Wagner, JE. (2007) Expanding the role of umbilical cord blood transplantation. Br J Haematol, 137, pp. 20-35.
4. Rocha, V., Wagner Jr, JE Sobocinski, KA et al. (2000) Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. New Eng J Med, 342, pp. 1846-1854.
5. van Burik, JA and Brunstein, CG. (2007) Infectious complications following unrelated cord blood transplantation. Vox Sang, 92, pp. 289-296.
6. Rocha, V., Labopin, M. Sanz, G. et al. (2004) Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med, 351, pp. 2276-2285.
7. Dalle, JH, Menezes, J. Wagner, E et al. (2005) Characterization of cord blood natural killer cells: Implications for transplantation and neonatal infections. Pediatr Res, 57, pp. 649-655.
8. Nguyen, QH, Roberts, RL Ank, BJ et al. (1998) Interleukin (IL)-15 enhances natural killer (NK) activity and antibody dependent cellular cytotoxicity (ADCC) in neonatal cells. Cell Immunol, 185, pp. 83-92.
9. Lin, SJ, Yang, MH Chao, HC et al. (2000) Effect of interleukin-15 and Flt3-ligand on natural killer cell expansion and activation: Umbilical vs adult peripheral blood mononuclear cells. Pediatr Allergy Immunol, 11, pp. 168-174.
10. Lin, SJ, Cheng, PJ Huang, YJ et al. (2004) Evaluation of interleukin(IL)-12/IL-15 activated umbilical cord blood natural killer cell cytotoxic function by a propidium-iodide based flow cytometry. Pediatr Allergy Immunol, pp. 1579-1585.
11. Tanaka, H., Kai, S. Yamaguchi, M. et al. (2003) Analysis of natural killer (NK) cell activity and adhesion molecules on NK cells from umbilical cord blood. Eur J Haematol, 71, pp. 29-38.
12. Introna, M., Franceschetti, M. Ciocca, A. et al. (2006) Rapid and massive expansion of cord blood-derived cytokine-induced killer cells: an innovative proposal for the treatment of leukemia relapse after cord blood transplantation. Bone Marrow Transplant, 38, pp. 621-627.
13. + natural killer cells. Hum Immunol, 62, pp. 1092-1098.
14. Klingemann, HG. (2005) Natural killer cell-based immunotherapeutic strategies. Cytotherapy, 7, pp. 16-22.
15. Choi, SS, Chhabra, VS Nguyen, QH et al. (2004) Interleukin-15 enhances cytotoxicity, receptor expression, and expansion of neonatal natural killer cells in long-term culture. Clin Diagn Lab Immunol, 11, pp. 879-888.
16. Lin, SJ, Wang, LY Huang, YJ et al. (2001) Effect of interleukin (IL)-12 and IL-15 on apoptosis and proliferation of umbilical cord blood mononuclear cells. Bone Marrow Transplant, 28, pp. 439-445.
17. McDouall, R., Suitters, A. Smith, H. et al. (1994) Increased cyclosporine sensitivity of T cells from cord blood compared with those from adult. Clin Exp Immunol, 95, pp. 519-524.
18. Introna, M., Allavena, P. Spreafico, F. et al. (1981) Inhibition of human natural killer activity by cyclosporine. Transplantation, 31, pp. 113-116.
19. Alamartine, E., Sabido, O. and Berthoux, F. (1994) In-vitro effects of cyclosporin A, FK506, 6-mercaptopurine, and prednisolone on lymphokine-activated killer cells. Nephrol Dial Transplant., 9, pp. 1456-1461.
20. Thomson, AW. (1992) The effects of cyclosporin A on non-T cell components of the immune system. J Autoimmunity, 5, pp. 167-176.
21. Petersson, E., Qi, Z. Ekberg, H. et al. (1997) Activation of alloreactive natural killer cells is resistant to cyclosporine. Transplantation, 63, pp. 1138-1144.
22. + natural killer cell subpopulations. Blood, 110, pp. 1530-1539.
23. Vermes, I., Haanen, C. Steffens-Nakken, H. et al. (1995) A novel assay for apoptosis: Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin-V. J Immunol Methods, 184, pp. 39-51.
24. Vosshenrich, CA, Ranson, T. Samson, SI et al. (2005) Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol, 174, pp. 1213-1221.
25. Cooper, MA, Bush, JE Fehniger, TA et al. (2002) In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood, 100, pp. 3633-3638.
26. Poggi, A. and Zocchi, MR. (2005) Cyclosporin A regulates human NK cell apoptosis induced by soluble HLA-I or by target cells. Autoimmun Rev, 4, pp. 532-536.
27. Lin, SJ, Chao, HC and Kuo, ML. (2000) Effect of interleukin(IL)-15 and IL-12 on CD69 expression of T-lymphocytes and natural killer cells from umbilical cord blood. Biol Neonate, 78, pp. 181-185.
28. Ortiz, AM, Garcia-Vicuna, R. Sancho, D. et al. (2000) Cyclosporin A inhibits CD69 expression induced on synovial fluid and peripheral blood lymphocytes by interleukin 15. J Rheumatol, 27, pp. 2329-2338.
29. Robertson, MJ, Caligiuri, MA Manley, TJ et al. (1990) Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis. J Immunol, 145, pp. 3194-3209.
30. Zhang, J., Sun, R. Wei, H. et al. (2004) Characterization of interleukin-15 gene-modified human natural killer cells: Implications for adoptive cellular immunotherapy. Haematologica, 89, pp. 338-347.
31. Schierloh, P., Aleman, M. Yokobori, N. et al. (2005) NK cell activity in tuberculosis is associated with impaired CD11a and ICAM-1 expression: A regulatory role of monocytes in NK activation. Immunology, 116, pp. 541-552.
32. Taga, K., Yamauchi, A. Kabashima, K. et al. (1996) Target-induced death by apoptosis in human lymphokine-activated natural killer cells. Blood, 87, pp. 2411-2418.